Contact
QR code for the current URL

Story Box-ID: 731411

Creathor Venture Management GmbH Schwedenpfad 24 61348 Bad Homburg, Germany http://www.creathor.de
Contact Ms Andrea Kaidel +49 6172 1397220
Company logo of Creathor Venture Management GmbH
Creathor Venture Management GmbH

Creathor joins Series C round of Sinopsys Surgical

(PresseBox) (Bad Homburg, Germany / Boulder, Colorado, USA, )
Creathor has invested into Sinopsys Surgical, a clinical stage medical device company in Boulder, Colorado. Sinopsys has developed a stent device called the Sinopsys Lacrimal Stent. The lead indication for the stent is chronic rhinosinusitis with additional use in epiphora and potential in allergic rhinitis.

Participants in this Series C round beside Creathor are strategic, institutional and private investors. All of the company's existing investors took part in the financing.

"The company is very grateful for the strong support from both its existing and new investors.", comments Harry Ross, CEO of Sinopsys, "We are eager to begin our next phase of U.S. trials in an exciting range of applications." he adds.

"The Sinopsys Lacrimal Stent has the potential to help millions of patients suffering from chronic rhinosinusitis, an indication with high medical need and limited therapeutic options", says Christian Leikert, Investment Manager at Creathor "We are looking forward to working with Sinopsys in this exiting environment."

The funds will be used to further develop the Sinopsys Lacrimal Stent in clinical trials and to prepare the regulatory filings as well as the market launch of the device.

Attachments

Website Promotion

Website Promotion

Creathor Venture Management GmbH

Creathor manages funds of more than EUR 180m and invests in technology-oriented companies and entrepreneurs in the mobile, social e-commerce, e-commerce, media, cloud, cleantech, life science and medtech industry. The management team of Creathor Venture consists of the CEO Dr. Gert Köhler, Cédric Köhler and Karlheinz Schmelig. The team has been investing successfully in the early-stage venture capital business for over 30 years. During that time, more than 200 technology companies have been funded, more than 20 international IPOs conducted and many companies were successfully sold. Creathor has achieved exceptional fund returns in the past.

Creathor Venture as a pan European Venture capital company holds offices in Bad Homburg, in Tutzing (near Munich), in Zurich and in Stockholm and supports a portfolio of over 30 innovative companies as lead-investor.

The investors of the current fund include the European Union, through which the fund receives funding from the "Competitiveness and Innovation Framework Programme" (CIP), and the "ERP EIF fund of funds" and the LfA - Gesellschaft für Vermögensverwaltung mbH, both facilities of the European Investment Fund ("EIF"), fund of funds, family offices and entrepreneurs. As the largest investor in Creathor (over EUR 50m) the management underlines its entrepreneurial orientation.

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.